Drug research

ADX-038

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as siRNA

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Chinese Adults With Kidney DiseaseNCT07522099	ADARx Pharmaceuticals, Inc.	Phase 2	Recruiting	2028-07-10Estimated
Phase 2 Study of ADX-038 in Participants With Geographic AtrophyNCT06990269	ADARx Pharmaceuticals, Inc.	Phase 2	Recruiting	2030-02-28Estimated

ADARx Pharmaceuticals, Inc.RecruitingPrimary completion: 2028-07-10 · Estimated

Trial details

ADARx Pharmaceuticals, Inc.RecruitingPrimary completion: 2030-02-28 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.